Commonwealth Equity Services’s Standard BioTools LAB Stock Holding History

Commonwealth Equity Services’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-113,000	Closed	-$198K	–	4230
2024 Q4	$198K	Sell	113,000 -51,993	-32%	-$96.8K	﹤0.01%	3763
2024 Q3	$318K	Buy	164,993 +8,802	+6%	+$17.2K	﹤0.01%	3300
2024 Q2	$276K	Hold	156,191	–	–	﹤0.01%	3361
2024 Q1	$423K	Buy	156,191 +113,277	+264%	+$273K	﹤0.01%	2963
2023 Q4	$95K	Buy	42,914 +12,832	+43%	+$27.4K	﹤0.01%	3678
2023 Q3	$87K	Hold	30,082	–	–	﹤0.01%	3586
2023 Q2	$58K	Hold	30,082	–	–	﹤0.01%	3647
2023 Q1	$58	Hold	30,082	–	–	﹤0.01%	3566
2022 Q4	$35K	Buy	30,082 +14,630	+95%	+$18K	﹤0.01%	3547
2022 Q3	$17K	Hold	15,452	–	–	﹤0.01%	3591
2022 Q2	$24K	Hold	15,452	–	–	﹤0.01%	3556
2022 Q1	$55K	Hold	15,452	–	–	﹤0.01%	3574
2021 Q4	$60K	Buy	+15,452	New	+$72.3K	﹤0.01%	3514
2020 Q4	–	Sell	-10,571	Closed	-$78K	–	3236
2020 Q3	$78K	Buy	+10,571	New	+$73K	﹤0.01%	2909

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Commonwealth Equity Services's LAB Position: Q1 2025 in Review

Commonwealth Equity Services sold out of Standard BioTools (LAB) in Q1 2025, closing a stake of 113,000 shares — an estimated $198K sold.

Commonwealth Equity Services first reported a position in LAB in Q3 2020 and held it in 14 quarters. The position peaked at $423K in Q1 2024. 145 funds tracked by Wall St. Rank hold LAB as of Q1 2025.

Commonwealth Equity Services reported no remaining Standard BioTools position as of Q1 2025 after selling out during the quarter.
Commonwealth Equity Services sold 113,000 Standard BioTools shares in Q1 2025, an estimated $198K.
Commonwealth Equity Services first reported a position in Standard BioTools in Q3 2020 and held it in 14 quarters.
Commonwealth Equity Services's Standard BioTools position peaked at $423K in Q1 2024.
145 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2025.

Based on Commonwealth Equity Services's 13F filing for Q1 2025, filed 9 May 2025.